AstraZeneca and Daiichi Sankyo’s Enhertu Improves PFS in First-Line HER2-Mutant Advanced NSCLC in Phase III DESTINY-Lung04
International Urology Cancer Summit and OncoDaily Announce Strategic Partnership
Using Lung Function Data to Refine Pulmonary Toxicity Risk Before Thoracic Radiotherapy
DESTINY-Lung04: Enhertu Improves First-Line PFS in HER2-Mutant NSCLC
AstraZeneca Discontinues Phase III eVOLVE-Lung02 Trial of Volrustomig Plus Chemotherapy in Metastatic NSCLC
Vivek Subbiah: Rethinking the Unified Cancer of Unknown Primary Concept
10 Must-Read Posts In GU Oncology This Week
Evelyn H. Lauder at 90: A Legacy That Transformed Breast Cancer Research
The ALRCaN (Acute Leukemia Research and Care Network) webinar, titled “Maintenance therapy of leukemia – A journey from empiric knowledge to basic science and a novel paradigm,” is scheduled for […]
The ALRCaN Global webinar, “Reliable leukemia subtyping with machine learning and conformal prediction?” is set for Friday, March 27, 2026, from 09:00 AM to 10:00 AM ET. Led by Mariya […]
The ALRCaN Global webinar, “Newly diagnosed AML: 2026 Treatment algorithms” is set for Friday, April 03, 2026, from 09:00 AM to 10:00 AM ET. Led by Dr. Naseema Gangat, this session examines current treatment strategies and algorithms for acute myeloid leukemia. Organized by ALRCaN Global and Resonance Health, and supported by Scott Howard, Stacy Cooper, […]
The ALRCaN Global webinar, “Optimizing Blinatumomab” is set for Friday, April 10 2026, from 09:00 AM to 10:00 AM ET. Led by Dr. Stacy Cooper, this session examines current treatment strategies and algorithms for acute myeloid leukemia. Organized by ALRCaN Global and Resonance Health, and supported by Scott Howard, Stacy Cooper, Archie Bleyer, and Dan Douer, this […]
The ALRCaN Global webinar, “Effects of Race and Ethnicity on Hematopoietic Stem Cell Transplant Outcomes in Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis,” is set for Friday, April 17, […]
The ALRCaN Global webinar, “Treatment Strategy for a 4-Year-Old Boy with Newly Diagnosed MLL-AF4-Positive B-ALL,” is set for Friday, April 24, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT). Led by Dr. Hisato Segoe, this session examines specialized clinical approaches for high-risk pediatric leukemia subtypes. Organized by the Acute […]
The ALRCaN Global webinar, “Scalp Cooling for Prevention of Hair Loss in Pediatric ALL,” is set for Friday, May 08, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT). Led by Dr. Aditya Kumar Gupta, this session examines the clinical utility and implementation of scalp cooling technologies to mitigate chemotherapy-induced […]
The ALRCaN Global webinar, “Incorporating Immunotherapy Into Upfront Ph-Negative Acute Lymphoblastic Leukemia Therapy,” is set for Friday, May 15, 2026, from 09:00 AM to 10:00 AM ET (05:00 PM – 06:00 PM AMT). Led by Dr. Mark Litzow, this session explores the evolving treatment landscape and clinical integration of immunotherapeutic agents into frontline regimens for […]
The ALRCaN (Acute Leukemia Research and Care Network) webinar, titled “Infantile Leukemia: Translating Protocol into Practice Through Clinical Experience,” is scheduled for Friday, May 22, 2026, from 05:00 to 06:00 PM (Armenia Standard Time). Presented by Fatimah Hashim, this session focuses on the translation of standardized leukemia protocols into real-world clinical practice, specifically addressing the […]
The ALRCaN (Acute Leukemia Research and Care Network) webinar, titled “C2S study: ‘Surviving cancer in India: giant leaps for humankind’,” is scheduled for Friday, May 29, 2026, from 05:00 to 06:00 PM (Armenia Standard Time). Presented by Ramandeep Arora, this session will explore the transformative advancements and systemic "leaps" in pediatric cancer survivorship across India. […]
The ALRCaN (Acute Leukemia Research and Care Network) webinar, titled “Journal Club with Scott,” is scheduled for Friday, June 05, 2026, from 05:00 to 06:00 PM (Armenia Standard Time). Presented by Scott Howard, this session will feature a lively discussion of leukemia and supportive care topics. This weekly collegial gathering, hosted by Resonance and part of the […]
The ALRCaN webinar on Friday, June 12, 2026, from 09:00 to 10:00 AM ET, will present “Long-term follow-up of the CALGB 10403 trial: New insights into AYA ALL.” Presented by Dr. Wendy Stock, this session delivers critical updates and data-driven insights from the long-term follow-up of this landmark trial, focusing on clinical outcomes for adolescent […]
The ALRCaN webinar on Friday, June 19, 2026, from 09:00 to 10:00 AM ET, will present “Therapeutic Advances in Infantile Acute Lymphoblastic Leukemia.” Presented by Dr. Tanja Gruber, this session will explore recent therapeutic developments and emerging treatment strategies for infantile acute lymphoblastic leukemia (ALL), highlighting advances in clinical research and their implications for patient […]
The ALRCaN Global webinar, “Global AYA ALL Status” is set for Friday, June 26, 2026, from 09:00 AM to 10:00 AM ET. Led by Dr. Archie Bleyer, this session provides a comprehensive update on the status of Acute Lymphoblastic Leukemia in Adolescents and Young Adults globally. Organized by ALRCaN Global and Resonance Health, and supported […]
The ALRCaN Global webinar, “Managing Early T-Cell Precursor ALL: A Case-Based Discussion,” is scheduled for Friday, July 10, 2026, from 09:00 AM to 10:00 AM ET. Presented by Dr. Lisa Hartman and Dr. David Teachey, this case-based session will focus on the management of early T-cell precursor acute lymphoblastic leukemia (ETP-ALL), highlighting clinical decision-making and […]
The ALRCaN Global webinar, "Asparaginase Therapeutic Drug Monitoring in Pediatric ALL: The Brazilian Experience from Implementation to Multicenter Research," is scheduled for Friday, July 17, 2026, from from 09:00 AM to 10:00 AM ET. Presented by Dr. Mariana Michalowski and organized by the Acute Leukemia Research and Care Network (ALRCaN), the webinar is part of […]
